John E. Davis sells AORT shares reported on Form 144
John E. Davis reported insider share transactions under Form 144 relating to AORT common stock.
Rhea-AI Filing Summary
John E. Davis reported insider share transactions under Form 144 relating to AORT common stock. The filing lists proposed restricted-stock vesting of 4,573 shares on 02/27/2026 and discloses sales executed in the prior three months: 3,773 shares on 02/23/2026 ($141,817.64), 2,075 shares on 02/24/2026 ($74,062.77), and 2,784 shares on 03/02/2026 ($105,861.32).
Positive
- None.
Negative
- None.
Insights
Routine Form 144 disclosure of insider sales and a restricted stock vesting.
The filing lists specific sale transactions by John E. Davis, showing exact share counts and gross proceeds for each trade dated 02/23/2026, 02/24/2026, and 03/02/2026. It also lists a restricted stock vesting of 4,573 shares on 02/27/2026.
These entries are procedural disclosures required for proposed sales; cash‑flow treatment to the issuer or holder is not stated in the excerpt. Subsequent filings or broker records would show final sale settlement details.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the AORT Form 144 filed by John E. Davis disclose?
How much gross proceeds were reported for the AORT insider sales?
Does this Form 144 indicate whether the issuer received proceeds?
AI-generated analysis. How Rhea-AI works. Not financial advice.